Effective MDS Therapy Remains Underutilized, Particularly Among Women and Non-White Patients
(WASHINGTON – August 6, 2025) – A striking new study has unveiled a troubling reality in the treatment landscape of high-risk myelodysplastic syndromes (MDS) in...
















